Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
This study is ongoing, but not recruiting participants.
Study NCT00021047 Information provided by National Cancer Institute (NCI)
First Received: July 11, 2001 Last Updated: December 13, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophageal Cancer
Extrahepatic Bile Duct Cancer
Gastric Cancer
Head and Neck Cancer
Liver Cancer
Additional conditions recognized in this trial
Bile Duct Neoplasms
Esophageal Diseases
Esophageal Neoplasms
Head and Neck Neoplasms
Liver Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Biliary Tract Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Liver Diseases
Neoplasms
Neoplasms by Site
Stomach Diseases
Interventions listed in this trial
capecitabine
carboplatin
epirubicin hydrochloride
Additional drug interventions recognized in this trial
Epirubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
